Savulich, G
Riccelli, R
Passamonti, L
Correia, M
Deakin, J F W
Elliott, R
Flechais, R S A
Lingford-Hughes, A R
McGonigle, J
Murphy, A
Nutt, D J
Orban, C
Paterson, L M
Reed, L J
Smith, D G
Suckling, J
Tait, R
Taylor, E M
Sahakian, B J
Robbins, T W
Ersche, K D
,
Article History
Received: 7 October 2016
Revised: 25 January 2017
Accepted: 25 January 2017
First Online: 7 March 2017
Competing interests
: JFWD currently advises or carries out research funded by Autifony, Sunovion, Lundbeck, AstraZeneca and Servier. All payment is to the University of Manchester. ARL-H has received honoraria from Lundbeck and research support from GSK for a PhD studentship. DJN is an advisor to British National Formulary, MRC, General Medical Council, Department of Health, is President of the European Brain Council, past President of the British Neuroscience Association and European College of Neuropsychopharmacology, chair of the Independent Scientific Committee on Drugs (UK), is a member of the International Centre for Science in Drug Policy, advisor to Swedish government on drug, alcohol and tobacco research, editor of the <i>Journal of Psychopharmacology</i>, sits on advisory Boards at Lundbeck, MSD, Nalpharm, Orexigen, Shire, has received speaking honoraria (in addition to above) from BMS/Otsuka, GSK, Lilly, Janssen, Servier, is a member of the Lundbeck International Neuroscience Foundation, has received grants or clinical trial payments from P1vital, MRC, NHS, Lundbeck, has share options with P1vital, has been expert witness in a number of legal cases relating to psychotropic drugs, and has edited/written 27 books, some purchased by pharmaceutical companies. BJS consults for Cambridge Cognition, Brainbow (Peak), Servier, Otsuka, and Lundbeck, holds a grant from Janssen/Johnson & Johnson, and has share options in Cambridge Cognition. Trevor Robbins has had research grants with Eli Lilly and Lundbeck, has received royalties from Cambridge Cognition (CANTAB), has received editorial honoraria from Springer Verlag, Elsevier, Society for Neuroscience; has performed educational lectures for Merck, Sharpe and Dohme and does consultancy work for Cambridge Cognition, Eli Lilly, Lundbeck, Teva and Shire Pharmaceuticals. The remaining authors declare no conflict of interest.